Table III.
Grade | Schedule A* (n = 29) | Schedule B† (n = 35) | Schedule C72‡ (n = 29) | Schedule C90§ (n = 20) | All patients (N = 113) | |||||
---|---|---|---|---|---|---|---|---|---|---|
Any | ≥3 | Any | ≥3 | Any | ≥3 | Any | ≥3 | Any | ≥3 | |
Haematological events, % | ||||||||||
Febrile neutropenia | 48 | 35 | 66 | 60 | 62 | 55 | 50 | 45 | 58 | 50 |
Thrombocytopenia | 45 | 45 | 69 | 69 | 69 | 62 | 60 | 60 | 61 | 59 |
Anaemia | 41 | 38 | 54 | 46 | 66 | 55 | 60 | 60 | 55 | 49 |
Neutropenia | 41 | 38 | 26 | 26 | 28 | 28 | 25 | 25 | 30 | 29 |
Leucopenia | 7 | 7 | 14 | 14 | 0 | 0 | 5 | 5 | 7 | 7 |
Non-haematological events, % | ||||||||||
Cardiac disorders | ||||||||||
Tachycardia | 38 | 0 | 40 | 0 | 17 | 0 | 25 | 5 | 31 | 1 |
Gastrointestinal disorders | ||||||||||
Diarrhoea | 83 | 7 | 77 | 6 | 69 | 0 | 65 | 10 | 74 | 5 |
Stomatitis/oral mucositis | 72 | 28 | 57 | 11 | 55 | 28 | 55 | 25 | 60 | 22 |
Nausea | 76 | 3 | 60 | 0 | 86 | 3 | 55 | 5 | 70 | 3 |
Vomiting | 55 | 0 | 29 | 0 | 52 | 7 | 25 | 0 | 41 | 2 |
Constipation | 41 | 0 | 37 | 0 | 17 | 0 | 20 | 0 | 30 | 0 |
Oral pain | 7 | 3 | 14 | 3 | 17 | 10 | 30 | 15 | 16 | 7 |
General disorders/administration site conditions | ||||||||||
Peripheral oedema | 59 | 10 | 49 | 3 | 52 | 3 | 40 | 0 | 50 | 4 |
Fatigue | 52 | 17 | 57 | 20 | 41 | 14 | 35 | 15 | 48 | 17 |
Asthenia | 31 | 10 | 40 | 9 | 21 | 7 | 10 | 0 | 27 | 7 |
Chills | 28 | 0 | 34 | 0 | 28 | 3 | 30 | 0 | 30 | 1 |
Pyrexia | 17 | 0 | 26 | 3 | 24 | 0 | 35 | 0 | 25 | 1 |
Infections and infestations | ||||||||||
Aggregate sepsis¶ | 52 | 55** | 43 | 34** | 21 | 24 | 45 | 45** | 40 | 39** |
Aggregate infections¶ | 45 | 21 | 37 | 6** | 45 | 10 | 35 | 20 | 41 | 13** |
Aggregate pneumonia¶ | 41 | 31** | 40 | 34** | 38 | 28 | 35 | 25** | 39 | 30** |
Metabolism and nutrition disorders | ||||||||||
Anorexia | 72 | 28 | 51 | 9 | 59 | 10 | 55 | 0 | 59 | 12 |
Hypokalaemia | 72 | 41 | 54 | 20 | 59 | 21 | 65 | 15 | 62 | 25 |
Hypomagnesaemia | 52 | 3 | 40 | 0 | 48 | 0 | 30 | 0 | 43 | 1 |
Hypophosphataemia | 45 | 24 | 23 | 3 | 21 | 7 | 25 | 15 | 28 | 12 |
Dehydration | 28 | 14 | 20 | 0 | 10 | 3 | 25 | 15 | 20 | 7 |
Hypocalcaemia | 28 | 14 | 14 | 6 | 31 | 10 | 20 | 10 | 23 | 10 |
Hyperglycaemia | 10 | 7 | 20 | 6 | 21 | 10 | 15 | 5 | 17 | 7 |
Nervous system disorders | ||||||||||
Headache | 35 | 0 | 26 | 3 | 31 | 3 | 10 | 0 | 27 | 2 |
Dizziness | 21 | 0 | 20 | 0 | 24 | 0 | 20 | 0 | 21 | 0 |
Psychiatric disorders | ||||||||||
Insomnia | 41 | 0 | 37 | 0 | 38 | 0 | 15 | 0 | 35 | 0 |
Confusional state | 28 | 14 | 26 | 0 | 28 | 3 | 10 | 5 | 24 | 5 |
Anxiety | 24 | 0 | 40 | 0 | 41 | 3 | 20 | 0 | 33 | 1 |
Respiratory, thoracic, and mediastinal disorders | ||||||||||
Cough | 45 | 0 | 31 | 0 | 38 | 0 | 25 | 0 | 35 | 0 |
Dyspnea | 38 | 24 | 40 | 9 | 38 | 3 | 25 | 15 | 36 | 12 |
Rales | 35 | 0 | 23 | 0 | 7 | 0 | 15 | 0 | 20 | 0 |
Epistaxis | 24 | 0 | 37 | 0 | 28 | 7 | 25 | 0 | 29 | 2 |
Pleural effusion | 24 | 0 | 23 | 9 | 38 | 0 | 10 | 0 | 25 | 3 |
Hypoxia | 10 | 7 | 17 | 14 | 21 | 3 | 10 | 0 | 15 | 7 |
Skin and subcutaneous tissue disorders | ||||||||||
Alopecia | 41 | 0 | 23 | 0 | 45 | 0 | 25 | 0 | 34 | 0 |
Petechiae | 28 | 0 | 31 | 0 | 14 | 0 | 0 | 0 | 20 | 0 |
Rash | 24 | 0 | 23 | 0 | 35 | 3 | 15 | 0 | 25 | 1 |
Vascular disorders | ||||||||||
Hypotension | 38 | 17 | 31 | 3 | 35 | 0 | 30 | 15 | 34 | 8 |
Hypertension | 21 | 10 | 11 | 9 | 10 | 3 | 0 | 0 | 12 | 6 |
72 mg/m2 on days 1, 8, and 15.
72 mg/m2 on days 1 and 8.
72 mg/m2 on days 1 and 4.
90 mg/m2 on days 1 and 4.
Aggregate sepsis includes sepsis, bacteraemia, viraemia and fungaemia, and represents 32 preferred terms; aggregate infections represent 30 preferred terms; aggregate pneumonia represents 10 preferred terms.
Includes 1 or more grade 5 events. Grade 5 aggregate sepsis was observed with schedules A (n = 4), B (n = 3), and C90 (n = 2); grade 5 aggregate pneumonia was observed with Schedules A (n = 1), B (n = 1), and C90 (n = 2); grade 5 aggregate infection was observed with Schedule B (n = 1).